Metric Deep Dive: Understanding Cerevel Therapeutics Holdings Inc (CERE) Through its Ratios

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

After finishing at $42.52 in the prior trading day, Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) closed at $42.26, down -0.61%. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 0.88 million shares were traded. CERE stock price reached its highest trading level at $42.53 during the session, while it also had its lowest trading level at $42.24.


Our goal is to gain a better understanding of CERE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.92 and its Current Ratio is at 10.92. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.71.

On September 28, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $33.Piper Sandler initiated its Overweight rating on September 28, 2023, with a $33 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’24 when COLES N ANTHONY sold 50,000 shares for $42.33 per share. The transaction valued at 2,116,640 led to the insider holds 15,638 shares of the business.

COLES N ANTHONY sold 50,000 shares of CERE for $2,050,550 on Mar 04 ’24. The Director now owns 15,638 shares after completing the transaction at $41.01 per share. On Feb 29 ’24, another insider, COLES N ANTHONY, who serves as the Director of the company, sold 50,000 shares for $41.16 each. As a result, the insider received 2,057,890 and left with 15,638 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CERE now has a Market Capitalization of 7686628352 and an Enterprise Value of 7163235328.

Stock Price History:

Over the past 52 weeks, CERE has reached a high of $43.59, while it has fallen to a 52-week low of $19.59. The 50-Day Moving Average of the stock is 0.63%, while the 200-Day Moving Average is calculated to be 27.06%.

Shares Statistics:

The stock has traded on average 1.40M shares per day over the past 3-months and 942580 shares per day over the last 10 days, according to various share statistics. A total of 181.36M shares are outstanding, with a floating share count of 87.15M. Insiders hold about 52.09% of the company’s shares, while institutions hold 48.51% stake in the company. Shares short for CERE as of 1713139200 were 7923837 with a Short Ratio of 5.66, compared to 1710460800 on 6962845. Therefore, it implies a Short% of Shares Outstanding of 7923837 and a Short% of Float of 9.15.

Most Popular

[the_ad id="945"]